3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Phase 2/3
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Polycystic Ovary Syndrome
1
Obesity
1
Interventions
Metformin
21
Letrozole
11
Clomiphene
7
dapagliflozin
4
Contraceptives, Oral
4
Chorionic Gonadotropin
4
cetrorelix
3
Liraglutide
3
Inositol
3
follitropin beta
2
follitropin alfa
2
drospirenone and ethinyl estradiol combination
2
Musculoskeletal Manipulations
2
Glycoprotein Hormones, alpha Subunit
2
DLBS3233
2
Cholecalciferol
2
semaglutide
1
saxagliptin
1
lime
1
follicle stimulating hormone, human, with HCG C-terminal peptide
1
drospirenone
1
cinnulin PF
1
Urofollitropin
1
Triptorelin Pamoate
1
Treatment Expectations
1
Thioctic Acid
1
Tamoxifen
1
Tablets
1
Sugars
1
Sperm Injections, Intracytoplasmic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Polycystic Ovary Syndrome
×
semaglutide
×
Clear all
NCT05819853
2025-08-28
RESTORE
University of Colorado, Denver
Phase 3
Recruiting
80 enrolled